CMV gB Antibody (1.B.223) is a mouse monoclonal IgG1 antibody that detects CMV gB of cytomegalovirus by western blotting (WB) and immunofluorescence (IF). CMV gB, or CMV glycoprotein B, plays a crucial role in the viral life cycle as CMV gB is essential for the infectivity of cytomegalovirus, facilitating virus entry into host cells. CMV gB (1.B.223) antibody targets a protein located in the viral envelope and is one of the most abundant components of the virion, making CMV gB a key target for immune response. The immunogenic nature of CMV gB means that a significant portion of virus-neutralizing antibodies are directed against this protein, highlighting CMV gB′s importance in vaccine development and therapeutic interventions. Anti-CMV gB antibody (1.B.223) recognizes a protein vital for controlling CMV infections, particularly in immunocompromised individuals who are at a higher risk of severe disease. CMV gB (1.B.223) monoclonal antibody helps researchers effectively study the expression and function of this critical protein, contributing to a better understanding of CMV pathogenesis and potential treatment strategies.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CMV gB Antibody (1.B.223) | sc-71228 | 100 µg/ml | $322.00 |